These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 17020421

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In vitro activity of nadifloxacin against both methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus from patients with skin infections.
    Nishijima S, Namura S, Akamatsu H, Kawai S, Asada Y, Kawabata S, Fujita M.
    Drugs; 1995; 49 Suppl 2():230-2. PubMed ID: 8549313
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
    Ruhe JJ, Smith N, Bradsher RW, Menon A.
    Clin Infect Dis; 2007 Mar 15; 44(6):777-84. PubMed ID: 17304447
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
    Sagransky M, Yentzer BA, Feldman SR.
    Expert Opin Pharmacother; 2009 Oct 15; 10(15):2555-62. PubMed ID: 19761357
    [Abstract] [Full Text] [Related]

  • 29. Expert committee recommendations for acne management.
    Zaenglein AL, Thiboutot DM.
    Pediatrics; 2006 Sep 15; 118(3):1188-99. PubMed ID: 16951015
    [Abstract] [Full Text] [Related]

  • 30. One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus.
    He L, Ta CN, Miño de Kaspar H.
    J Cataract Refract Surg; 2009 Oct 15; 35(10):1715-8. PubMed ID: 19781465
    [Abstract] [Full Text] [Related]

  • 31. Activity of nadifloxacin and three other antimicrobial agents against Cutibacterium acnes isolated from patients with acne vulgaris.
    Nenoff P, Koch D, Krüger C, Neumeister C, Götz MR, Schwantes U, Bödeker RH, Borelli C.
    J Eur Acad Dermatol Venereol; 2021 Oct 15; 35(10):e682-e684. PubMed ID: 34018651
    [No Abstract] [Full Text] [Related]

  • 32. Antibiotic treatment for acne vulgaris.
    Webster GF, Graber EM.
    Semin Cutan Med Surg; 2008 Sep 15; 27(3):183-7. PubMed ID: 18786496
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities.
    Niebuhr M, Mai U, Kapp A, Werfel T.
    Exp Dermatol; 2008 Nov 15; 17(11):953-7. PubMed ID: 18557929
    [Abstract] [Full Text] [Related]

  • 35. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization.
    Tanghetti EA, Popp KF.
    Dermatol Clin; 2009 Jan 15; 27(1):17-24. PubMed ID: 18984364
    [Abstract] [Full Text] [Related]

  • 36. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
    Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM.
    Mol Pharm; 2009 Jan 15; 6(5):1388-401. PubMed ID: 19473014
    [Abstract] [Full Text] [Related]

  • 37. Methicillin-resistant Staphylococcus aureus infections.
    Abrahamian FM, Moran GJ.
    N Engl J Med; 2007 Nov 15; 357(20):2090; author reply 2090. PubMed ID: 18003971
    [No Abstract] [Full Text] [Related]

  • 38. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.
    Draelos ZD, Carter E, Maloney JM, Elewski B, Poulin Y, Lynde C, Garrett S, United States/Canada Dapsone Gel Study Group.
    J Am Acad Dermatol; 2007 Mar 15; 56(3):439.e1-10. PubMed ID: 17208334
    [Abstract] [Full Text] [Related]

  • 39. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
    Bernard P, Jarlier V, Santerre-Henriksen A.
    Ann Dermatol Venereol; 2008 Jan 15; 135(1):13-9. PubMed ID: 18342068
    [Abstract] [Full Text] [Related]

  • 40. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
    Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA.
    Ann Emerg Med; 2008 Mar 15; 51(3):291-8. PubMed ID: 18222564
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.